mechlorethamine has been researched along with butyric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grunicke, H; Helliger, W; Hermann, BJ; Höck, W; Hofmann, J; Puschendorf, B | 1 |
| Csordas, A; Grunicke, H; Hauptlorenz, S; Helliger, W; Loidl, A; Multhaup, I; Puschendorf, B; Zwierzina, H | 1 |
| Bhatia, U; Darzynkiewicz, Z; Traganos, F | 1 |
3 other study(ies) available for mechlorethamine and butyric acid
| Article | Year |
|---|---|
Alkylating antitumor agents reduce histone acetyl-transferase activity.
Topics: Acetylation; Acetyltransferases; Animals; Butyrates; Butyric Acid; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Cells, Cultured; Cyclophosphamide; DNA Repair; Electrophoresis, Polyacrylamide Gel; Histone Acetyltransferases; Mechlorethamine; Saccharomyces cerevisiae Proteins | 1986 |
Depression of histone acetylation by alkylating antitumor agents: significance for antitumor activity and possible biological consequences.
Topics: Alkylation; Animals; Butyrates; Butyric Acid; Carcinoma, Ehrlich Tumor; Chromatin; Cyclophosphamide; Electrophoresis, Polyacrylamide Gel; Histones; In Vitro Techniques; Mechlorethamine; Mice; Phospholipids; Puromycin; Rats; Transcription, Genetic; Triaziquone | 1984 |
Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA-damaging drugs.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Apoptosis; Azacitidine; Butyrates; Butyric Acid; Camptothecin; Cell Differentiation; DNA Damage; Enzyme Inhibitors; Humans; Mechlorethamine; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1995 |